2024 YR4, an asteroid discovered last year, poses a potential threat to the Moon and our satellites. With a 4% chance of impact, scientists are exploring options to mitigate risks and maximize the chance for a spectacular meteor shower.
OpenAI, Oracle, and SoftBank announce five new AI data center sites, boosting their Stargate project to 7 gigawatts of capacity and creating over 25,000 jobs across the U.S. This expansion accelerates their $500 billion commitment to AI infrastructure.
In a candid interview, Kamala Harris opens up about her regrets regarding Joe Biden's reelection decision, revealing her internal struggle and the emotional toll of the 2024 campaign.
Users are discovering a hidden 50% renewal discount for Nest Aware subscriptions, cutting the annual fee from $100 to just $50! This exclusive offer seems to activate upon cancellation attempts, but is limited to US users only.
Sony launches its Franchise Rewards program, offering exclusive Ghost of Tsushima merchandise for trophy completion. Get your t-shirt and pin now!
Nvidia's CEO Jensen Huang and OpenAI's Sam Altman voiced support for Trump's new $100,000 H-1B visa fee, claiming it could attract top talent to the U.S. However, critics warn it may hinder innovation by limiting access to skilled workers.
In a surprising turn of events, France has officially recognized a Palestinian state, defying the Trump administration's attempts to undermine the initiative. Secretary of State Marco Rubio vehemently opposed this move, branding it as a 'gift to Hamas.'
The Supreme Court is set to hear a pivotal case on whether President Trump can legally fire FTC Commissioner Rebecca Kelly Slaughter, challenging decades-old restrictions on presidential power over federal agencies.
As France and Saudi Arabia push for a two-state solution, Israel responds with anger, declaring a Palestinian state will not happen. Retaliation is on the table as tensions escalate.
In a controversial announcement, the Trump administration warns that Tylenol use during pregnancy may be linked to autism. The FDA recommends limiting its use, despite ongoing debates among medical experts and manufacturers.
